472 related articles for article (PubMed ID: 26715844)
1. Adherence to GOLD guideline treatment recommendations among pulmonologists in Turkey.
Sen E; Guclu SZ; Kibar I; Ocal U; Yilmaz V; Celik O; Cimen F; Topcu F; Orhun M; Tereci H; Konya A; Ar I; Saryal S
Int J Chron Obstruct Pulmon Dis; 2015; 10():2657-63. PubMed ID: 26715844
[TBL] [Abstract][Full Text] [Related]
2. Categorization of COPD patients in Turkey via GOLD 2013 strategy document: ALPHABET study.
Gunen H; Yilmaz M; Aktas O; Ergun P; Ortakoylu MG; Demir A; Cetinkaya P; Gurgun A; Otlu M; Cilli A; Yilmaz U; Kokturk N; Candemir I; Yakar HI; Ar I; Konya A
Int J Chron Obstruct Pulmon Dis; 2015; 10():2485-94. PubMed ID: 26622176
[TBL] [Abstract][Full Text] [Related]
3. A cross-sectional survey of current treatment and symptom burden of patients with COPD consulting for routine care according to GOLD 2014 classifications.
Ding B; Small M; Holmgren U
Int J Chron Obstruct Pulmon Dis; 2017; 12():1527-1537. PubMed ID: 28579771
[TBL] [Abstract][Full Text] [Related]
4. Respiratory medication used in COPD patients from seven Latin American countries: the LASSYC study.
Casas A; Montes de Oca M; Menezes AM; Wehrmeister FC; Lopez Varela MV; Mendoza L; Ramírez L; Miravitlles M
Int J Chron Obstruct Pulmon Dis; 2018; 13():1545-1556. PubMed ID: 29785104
[TBL] [Abstract][Full Text] [Related]
5. Adherence to a COPD treatment guideline among patients in Hong Kong.
Chan KP; Ko FW; Chan HS; Wong ML; Mok TY; Choo KL; Hui DS
Int J Chron Obstruct Pulmon Dis; 2017; 12():3371-3379. PubMed ID: 29238182
[TBL] [Abstract][Full Text] [Related]
6. The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK.
Brusselle G; Price D; Gruffydd-Jones K; Miravitlles M; Keininger DL; Stewart R; Baldwin M; Jones RC
Int J Chron Obstruct Pulmon Dis; 2015; 10():2207-17. PubMed ID: 26527869
[TBL] [Abstract][Full Text] [Related]
7. Real-life evaluation of COPD treatment in a Bulgarian population: a 1-year prospective, observational, noninterventional study.
Ivanov Y; Nikolaev I; Nemeth I
Int J Chron Obstruct Pulmon Dis; 2018; 13():653-663. PubMed ID: 29503539
[TBL] [Abstract][Full Text] [Related]
8. An evaluation of early medication use for COPD: a population-based cohort study.
Falk J; Dik N; Bugden S
Int J Chron Obstruct Pulmon Dis; 2016; 11():3101-3108. PubMed ID: 27994449
[TBL] [Abstract][Full Text] [Related]
9. Adherence to current guidelines for chronic obstructive pulmonary disease (COPD) among patients treated with combination of long-acting bronchodilators or inhaled corticosteroids.
Asche CV; Leader S; Plauschinat C; Raparla S; Yan M; Ye X; Young D
Int J Chron Obstruct Pulmon Dis; 2012; 7():201-9. PubMed ID: 22500120
[TBL] [Abstract][Full Text] [Related]
10. Management of COPD in the UK primary-care setting: an analysis of real-life prescribing patterns.
Price D; West D; Brusselle G; Gruffydd-Jones K; Jones R; Miravitlles M; Rossi A; Hutton C; Ashton VL; Stewart R; Bichel K
Int J Chron Obstruct Pulmon Dis; 2014; 9():889-904. PubMed ID: 25210450
[TBL] [Abstract][Full Text] [Related]
11. The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK.
Edwards SC; Fairbrother SE; Scowcroft A; Chiu G; Ternouth A; Lipworth BJ
Int J Chron Obstruct Pulmon Dis; 2016; 11():2851-2858. PubMed ID: 27920512
[TBL] [Abstract][Full Text] [Related]
12. Pulmonologists Adherence to the Chronic Obstructive Pulmonary Disease GOLD Guidelines: A Goal to Improve.
Rajnoveanu RM; Rajnoveanu AG; Ardelean AB; Todea DA; Pop CM; Antoniu SA; Motoc NS; Chis AF; Fildan AP; Man MA
Medicina (Kaunas); 2020 Aug; 56(9):. PubMed ID: 32825456
[No Abstract] [Full Text] [Related]
13. Factors influencing treatment escalation from long-acting muscarinic antagonist monotherapy to triple therapy in patients with COPD: a retrospective THIN-database analysis.
Hurst JR; Dilleen M; Morris K; Hills S; Emir B; Jones R
Int J Chron Obstruct Pulmon Dis; 2018; 13():781-792. PubMed ID: 29551894
[TBL] [Abstract][Full Text] [Related]
14. Initiation of triple therapy maintenance treatment among patients with COPD in the US.
Simeone JC; Luthra R; Kaila S; Pan X; Bhagnani TD; Liu J; Wilcox TK
Int J Chron Obstruct Pulmon Dis; 2017; 12():73-83. PubMed ID: 28053518
[TBL] [Abstract][Full Text] [Related]
15. Inhaled treatment of COPD: a Delphi consensus statement.
Ninane V; Corhay JL; Germonpré P; Janssens W; Joos GF; Liistro G; Vincken W; Gurdain S; Vanvlasselaer E; Lehouck A
Int J Chron Obstruct Pulmon Dis; 2017; 12():793-801. PubMed ID: 28293106
[TBL] [Abstract][Full Text] [Related]
16. COPD patients' characteristics, usual care, and adherence to guidelines: the Greek UNLOCK study.
Tsiligianni I; Kampouraki M; Ierodiakonou D; Poulonirakis I; Papadokostakis P
Int J Chron Obstruct Pulmon Dis; 2019; 14():547-556. PubMed ID: 30880944
[TBL] [Abstract][Full Text] [Related]
17. How far is real life from COPD therapy guidelines? An Italian observational study.
Corrado A; Rossi A
Respir Med; 2012 Jul; 106(7):989-97. PubMed ID: 22483189
[TBL] [Abstract][Full Text] [Related]
18. The reasons for triple therapy in stable COPD patients in Japanese clinical practice.
Miyazaki M; Nakamura H; Takahashi S; Chubachi S; Sasaki M; Haraguchi M; Terai H; Ishii M; Fukunaga K; Tasaka S; Soejima K; Asano K; Betsuyaku T;
Int J Chron Obstruct Pulmon Dis; 2015; 10():1053-9. PubMed ID: 26082629
[TBL] [Abstract][Full Text] [Related]
19. Treatment trends in patients with asthma-COPD overlap syndrome in a COPD cohort: findings from a real-world survey.
Ding B; Small M
Int J Chron Obstruct Pulmon Dis; 2017; 12():1753-1763. PubMed ID: 28670116
[TBL] [Abstract][Full Text] [Related]
20. Inverse relationship between nonadherence to original GOLD treatment guidelines and exacerbations of COPD.
Foda HD; Brehm A; Goldsteen K; Edelman NH
Int J Chron Obstruct Pulmon Dis; 2017; 12():209-214. PubMed ID: 28123293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]